The BARD score was developed as another simple scoring tool to predict advanced fibrosis, originally in a cohort of people with MASLD.52 A discrete numerical score of 0–4 is derived by giving one point for individuals with BMI≥28.0 kg/m2, two points if the AST:ALT ratio is >0.8 and a further point if there is a history of T2D. Here, GPT is linked to type 2 diabetes mellitus.